Canertinib 2HCl
Canertinib 2HCl, an irreversible quinazoline-based HER family tyrosine kinase inhibitor, inhibits EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM respectively. Phase II.
| Trivial name | Canertinib; CI 1033 2HCl; PD 183805 2HCl |
| Catalog Number | CSN10535 |
| Alternative Name(s) | Canertinib; CI 1033 2HCl; PD 183805 2HCl |
| Research Area | Cancer |
| Molecular Formula | C24H27Cl3FN5O3 |
| CAS# | 289499-45-2 |
| Purity | ≥99% |
| SMILES | C=CC(NC1=C(C=C2C(C(NC3=CC(Cl)=C(C=C3)F)=NC=N2)=C1)OCCCN4CCOCC4)=O.[H]Cl.[H]Cl |
| Size | 250mg |
| Supplier Page | https://www.csnpharm.com/products/canertinib-2hcl.html |